Let’s get caught up with the latest innovation news from Xconomy Texas.
—When you spent your childhood in places like Dakar, Senegal, and Beirut, perhaps it’s not so surprising that, in adulthood, your travel itinerary would include the South Pole and... Read more »
C.A. Webb is leaving Underscore.VC, the Boston early-stage venture firm that she helped start less than two years ago.
Webb, Underscore’s co-founder and community partner, announced her departure in a Medium post on Monday. She attributed the move to the evolution... Read more »
Early-stage tech entrepreneurs in Michigan now have a new source of investment capital to chase.
Grand Rapids, MI-based Grand Ventures, established earlier this month by McKeel Hagerty of Hagerty Insurance and Huron River Ventures’ Tim Streit, will provide support... Read more »
La Jolla Pharmaceutical’s experimental drug to treat a deadly blood pressure condition hit its main goal in a Phase 3 clinical trial, boosting the company’s stock price by more than 75 percent on Monday morning.
San Diego-based La Jolla (NASDAQ: LJPC)... Read more »
Two newly approved drugs slow the progression of the rare and deadly Duchenne muscular dystrophy, but nothing on the market actually reverses the march of the disease. An emerging group of experimental gene therapy and gene editing treatments designed to do... Read more »
Houston—As children, many of us believed we would have out-of-this-world experiences as adults. Scott Parazynksi is actually living that childhood wish.
As a NASA astronaut, Parazynski has flown on five shuttle missions and completed seven spacewalks, including at the International... Read more »
Advaxis and Sellas Life Sciences Group, two companies that have pursued different ways of prompting the body’s immune system to fight cancer, are now hoping that combining their efforts will lead to a more precise treatment.
The agreement between the companies... Read more »
A year after selling his latest biotech startup—the second since 2012—Michael Gilman is back. He emerged today as chairman and CEO of a two-year-old startup named Arrakis Therapeutics, which aims to use chemical drugs to go after an unlikely target: RNA,... Read more »
This week, a welcome sign of spring: the first crocuses poked out of the ground near here. More construction is sure to follow. The U District upzone was approved, making way for more development near the University of Washington. Apple made... Read more »
BioCrossroads, a public-private collaboration that supports Indiana’s life sciences industry, released a report this week highlighting the sector’s economic activity in 2016—and the numbers indicate steady, incremental growth, says project director Brian Stemme.
BioCrossroads’ most recently available data show the... Read more »
San Antonio — Xenex Disinfection Services, the maker of a robot that rids hospital rooms of tiny bacteria and viruses that can potentially cause deadly infections, has raised $38 million of venture funding to hire new salespeople and spend more on... Read more »
Two months after the FDA rejected Cempra’s lead drug, a different antibiotic from the drug developer is now showing promise as a potential treatment for aggressive skin infections such as MRSA.
Chapel Hill, NC-based Cempra (NASDAQ: CEMP) said that early... Read more »
If you are the founder of a fledgling business, there are many things that are under your control, but also some that are not.
For instance, entrepreneurs working to develop tools to help hospitals get reimbursed for providing care have likely... Read more »